Fig. 5 | Scientific Reports

Fig. 5

From: Effect of Lacticaseibacillus rhamnosus IDCC 3201 on irritable bowel syndrome with constipation: a randomized, double-blind, and placebo-controlled trial

Fig. 5

Beta-diversity using non-metric multidimensional scaling (NMDS) and the Bray-Curtis dissimilarity index of fecal microbiome from the placebo and RH 3201 groups. Microbial communities of (A) baseline (0-week), (B) 4-week, and (C) 8-week between the placebo and RH 3202 groups. (D and E) Microbial communities in (D) placebo and (E) RH 3201 group during the intervention periods.

Back to article page